Why is this the must attend event for the industry?
Australia represents a small but highly developed pharmaceutical industry. The total value of the local market now sits at over US$8.5 billion, with generics accounting for a 15% share. With every key global generics sector growing at a significantly higher rate than branded markets and 12 of the 35 worldwide leading molecules coming off patent by 2009, the Australian generics market looks set to explode.
The 2nd annual Generic Medicines Australia conference comes at a time when the innovative strategies and solutions provided by generic medicines stakeholders will dramatically impact the market’s profitability. With investors looking to capitalise on industry expansion and legislation encouraging market growth, one thing is clear for the 21st century generic medicines industry - innovate or get left behind.
If you are involved in the business of generic medicine, then this is the place where you will meet and form relationships with the industry leaders, enabling you to develop your business model and learn the latest innovations from market pioneers.
What are the issues affecting the future of the generic medicines industry in Australia?
Government policy reform, regulation, funding
Global consolidation and intense international interest
Pioneering new means of pharmacy relations
Intensified evergreening motions from R&D pharma and inventive offerings from IP strategists
Increased merger and acquisition activity
New business models incorporating vertical integration
The expanding field of biosimilars
Novel systems of supply and distribution
The image of generic medicines in Australia
Supergenerics and generics-plus offerings
Innovative marketing strategies from non-generics industries
